Serum sclerostin decreases following 12months of resistance- or jump-training in men with low bone mass.

[1]  J. Greeves,et al.  Increased density and periosteal expansion of the tibia in young adult men following short-term arduous training. , 2016, Bone.

[2]  G. Banfi,et al.  Implications of exercise-induced adipo-myokines in bone metabolism , 2016, Endocrine.

[3]  B. Falk,et al.  Differential sclerostin and parathyroid hormone response to exercise in boys and men , 2016, Osteoporosis International.

[4]  V. Tillmann,et al.  Increased sclerostin and preadipocyte factor-1 levels in prepubertal rhythmic gymnasts: associations with bone mineral density, body composition, and adipocytokine values , 2016, Osteoporosis International.

[5]  P. Hinton,et al.  Effectiveness of resistance training or jumping-exercise to increase bone mineral density in men with low bone mass: A 12-month randomized, clinical trial. , 2015, Bone.

[6]  M. Tsironi,et al.  Changes in Serum Levels of Myokines and Wnt-Antagonists after an Ultramarathon Race , 2015, PloS one.

[7]  Mark L. Johnson,et al.  In vivo mechanical loading rapidly activates β-catenin signaling in osteocytes through a prostaglandin mediated mechanism. , 2015, Bone.

[8]  Joseph D. Gardinier,et al.  PTH Signaling During Exercise Contributes to Bone Adaptation , 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  S. Walrand,et al.  Muscle and bone, two interconnected tissues , 2015, Ageing Research Reviews.

[10]  Hafiz M. R. Khan,et al.  The Impact of Red Light Cameras on Crashes Within Miami–Dade County, Florida , 2015, Traffic injury prevention.

[11]  G. Banfi,et al.  Bone‐muscle unit activity, salivary steroid hormones profile, and physical effort over a 3‐week stage race , 2015, Scandinavian journal of medicine & science in sports.

[12]  D. Mellström,et al.  Exercise During Growth and Young Adulthood Is Independently Associated With Cortical Bone Size and Strength in Old Swedish Men , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[13]  G. Livshits,et al.  Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption–formation cycles? , 2014, Osteoporosis International.

[14]  Yi-Xian Qin,et al.  Dynamic fluid flow stimulation on cortical bone and alterations of the gene expressions of osteogenic growth factors and transcription factors in a rat functional disuse model. , 2014, Archives of biochemistry and biophysics.

[15]  L. Bonewald,et al.  Osteocyte-derived insulin-like growth factor I is essential for determining bone mechanosensitivity. , 2013, American journal of physiology. Endocrinology and metabolism.

[16]  M. Bouxsein,et al.  Serum sclerostin increases in healthy adult men during bed rest. , 2012, Journal of Clinical Endocrinology and Metabolism.

[17]  C. Qualls,et al.  Weight loss in obese older adults increases serum sclerostin and impairs hip geometry but both are prevented by exercise training , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[18]  T. Pieber,et al.  Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults. , 2012, The Journal of clinical endocrinology and metabolism.

[19]  G. Banfi,et al.  Sclerostin concentrations in athletes: role of load and gender. , 2012, Journal of biological regulators and homeostatic agents.

[20]  P. Parini,et al.  Physical training increases osteoprotegerin in postmenopausal women , 2012, Journal of Bone and Mineral Metabolism.

[21]  P. Hinton,et al.  Acute response of plasma markers of bone turnover to a single bout of resistance training or plyometrics. , 2011, Journal of applied physiology.

[22]  S. Mohan,et al.  Conditional disruption of IGF-I gene in type 1α collagen-expressing cells shows an essential role of IGF-I in skeletal anabolic response to loading. , 2011, American journal of physiology. Endocrinology and metabolism.

[23]  O. Tørring,et al.  Emerging anabolic treatments in osteoporosis. , 2011, Current drug safety.

[24]  L. Lanyon,et al.  Role of Endocrine and Paracrine Factors in the Adaptation of Bone to Mechanical Loading , 2011, Current osteoporosis reports.

[25]  P. Kostenuik,et al.  Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women. , 2010, The Journal of clinical endocrinology and metabolism.

[26]  Lance E. Lanyon,et al.  Mechanical Loading-Related Bone Gain Is Enhanced by Tamoxifen but Unaffected by Fulvestrant in Female Mice , 2010, Endocrinology.

[27]  C. Turner,et al.  Sclerostin: A gem from the genome leads to bone‐building antibodies , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[28]  S. Yakar,et al.  Sex‐specific regulation of body size and bone slenderness by the acid labile subunit , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[29]  P. Mcneil,et al.  Role of muscle-derived growth factors in bone formation. , 2010, Journal of musculoskeletal & neuronal interactions.

[30]  Yoshiaki Kawano,et al.  Mechano-transduction in Osteoblastic Cells Involves Strain-regulated Estrogen Receptor α-mediated Control of Insulin-like Growth Factor (IGF) I Receptor Sensitivity to Ambient IGF, Leading to Phosphatidylinositol 3-Kinase/AKT-dependent Wnt/LRP5 Receptor-independent Activation of β-Catenin Signaling , 2009, The Journal of Biological Chemistry.

[31]  L. Lanyon,et al.  Regulation of bone mass: Local control or systemic influence or both? , 2009 .

[32]  William E Grizzle,et al.  Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group. , 2009, Journal of proteome research.

[33]  Mark L. Johnson,et al.  Osteocytes, mechanosensing and Wnt signaling. , 2008, Bone.

[34]  Matthew R Allen,et al.  Mechanical Stimulation of Bone in Vivo Reduces Osteocyte Expression of Sost/Sclerostin* , 2008, Journal of Biological Chemistry.

[35]  M. Allende-Vigo.  The use of biochemical markers of bone turnover in osteoporosis. , 2007, Puerto Rico health sciences journal.

[36]  K. Michaëlsson,et al.  Leisure Physical Activity and the Risk of Fracture in Men , 2007, PLoS medicine.

[37]  Mark L. Johnson,et al.  Wnt/β-Catenin Signaling Is a Normal Physiological Response to Mechanical Loading in Bone* , 2006, Journal of Biological Chemistry.

[38]  J. Aronson,et al.  Effects of Systemic and Local Administration of Recombinant Human IGF‐I (rhIGF‐I) on De Novo Bone Formation in an Aged Mouse Model , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[39]  A. Robling,et al.  The Wnt Co-receptor LRP5 Is Essential for Skeletal Mechanotransduction but Not for the Anabolic Bone Response to Parathyroid Hormone Treatment* , 2006, Journal of Biological Chemistry.

[40]  Alexander G Robling,et al.  Biomechanical and molecular regulation of bone remodeling. , 2006, Annual review of biomedical engineering.

[41]  R. Swaminathan,et al.  Investigating the role of the growth hormone-insulin-like growth factor (GH-IGF) axis as a determinant of male bone mineral density (BMD). , 2005, Bone.

[42]  R. Jilka,et al.  Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis. , 2005, Endocrinology.

[43]  C. Rosen.  Insulin-like growth factor I and bone mineral density: experience from animal models and human observational studies. , 2004, Best practice & research. Clinical endocrinology & metabolism.

[44]  D. Bikle,et al.  Skeletal Unloading Induces Resistance to Insulin‐Like Growth Factor‐I (IGF‐I) by Inhibiting Activation of the IGF‐I Signaling Pathways , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[45]  D. Ginzinger,et al.  Skeletal unloading induces resistance to insulin-like growth factor I on bone formation. , 2003, Bone.

[46]  C. Rosen.  IGF-I and osteoporosis. , 2000, Clinics in laboratory medicine.

[47]  W. Parkhouse,et al.  IGF-1 bioavailability is increased by resistance training in older women with low bone mineral density , 2000, Mechanisms of Ageing and Development.

[48]  R. Eastell,et al.  The Use of Biochemical Markers of Bone Turnover in Osteoporosis , 2000, Osteoporosis International.

[49]  D. Leroith,et al.  Normal growth and development in the absence of hepatic insulin-like growth factor I. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[50]  D. Kiel,et al.  Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study. , 1998, The Journal of clinical endocrinology and metabolism.

[51]  L. Donahue,et al.  Circulating and skeletal insulin-like growth factor-I (IGF-I) concentrations in two inbred strains of mice with different bone mineral densities. , 1997, Bone.

[52]  J. Chow,et al.  Osteocytic expression of mRNA for c-fos and IGF-I: an immediate early gene response to an osteogenic stimulus. , 1996, The American journal of physiology.

[53]  Frost Hm,et al.  The mechanostat: a proposed pathogenic mechanism of osteoporoses and the bone mass effects of mechanical and nonmechanical agents. , 1987 .

[54]  H. Frost,et al.  The mechanostat: a proposed pathogenic mechanism of osteoporoses and the bone mass effects of mechanical and nonmechanical agents. , 1987, Bone and mineral.